Phase 1 Trial Set to Test First Live Biotherapeutics in Parkinson’s
The U.S. Food and Drug Administration (FDA) has approved 4D Pharma’s request to launch a Phase 1 clinical trial in…
Articles by Marta Figueiredo, PhD
Parkinson’s Less Likely After a Heart Attack, Danish Study Finds
People who have had a heart attack are at lower risk of developing Parkinson’s disease later in life relative…
Study Will Assess Benefits of Singing
Researchers at Iowa State University are evaluating whether four months of group singing sessions can improve breathing and swallowing in people…
Vitamin D May Help Brain Cells Clear Toxic Protein in Parkinson’s
Parkinson’s patients have a subpopulation of astrocytes — brain cells that support neuronal function and health — that produce…
GI Dysfunction Can Impair Effects of Duodopa/Duopa
Gastrointestinal (GI) dysmotility, or lack of movement, can impair the absorption and delay the effects of levodopa-based medication in people…
How Enzyme Works to Produce Dopamine in Brain Detailed in Study
A collaborative effort between researchers in Spain and Norway is helping to enrich an understanding of the regulatory mechanisms behind…
GBA and APOE Mutations Linked to Cognitive Decline, Dementia Risk
Among Parkinson’s patients, those carrying GBA and APOE gene mutations have a significantly faster cognitive decline and a higher risk of progression…
Ongentys as ‘Off’ Time Add-on Therapy in Scotland’s Health Service
The Scottish Medicines Consortium (SMC) has added Ongentys (opicapone) — an add-on oral therapy to levodopa/Dopa decarboxylase inhibitors…
Levodopa’s Ability to Bind Iron May Be Cause of Its Problems Over Time
L-dopa or levodopa, a standard treatment for Parkinson’s disease, forms a stable complex with iron and siderocalin, a…
Traumatic Brain Injury Accelerates Onset by 5 Years, Study Suggests
Experiencing a traumatic brain injury (TBI) is associated with an earlier age of Parkinson’s onset, but not with more…